With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Accessnews2026-07-24T11:29:04+00:00July 24th, 2026|The New York Times|
With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Accessnews2026-07-24T11:29:04+00:00July 24th, 2026|The New York Times|
Ladrones de Ozempic: la nueva ola delictiva en Brasilnews2025-02-15T10:10:09+00:00February 15th, 2025|The New York Times|
Armed Bandits in Brazil Pursue New Loot: Ozempicnews2025-02-15T10:01:02+00:00February 15th, 2025|The New York Times|
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countriesnews2024-10-02T23:12:20+00:00October 2nd, 2024|The New York Times|
La nueva realidad mundial del dengue exige encontrar una mejor vacunanews2024-04-13T07:01:05+00:00April 13th, 2024|The New York Times|
The Push for a Better Dengue Vaccine Grows More Urgentnews2024-04-12T00:35:07+00:00April 12th, 2024|The New York Times|
‘Miracle’ Cystic Fibrosis Drug Kept Out of Reach in Developing Countriesnews2023-02-07T21:15:45+00:00February 7th, 2023|The New York Times|
A Dilemma for Governments: How to Pay for Million-Dollar Therapiesnews2023-01-25T00:27:17+00:00January 25th, 2023|The New York Times|
Monkeypox Shots, Treatments and Tests Are Unavailable in Much of the Worldnews2022-09-12T11:30:34+00:00September 12th, 2022|The New York Times|
